The first official medical cannabis shipment has been delivered from Portugal to Germany, and is one of the largest shipments to be sent to Germany from another European Union member country so far.
According to the Financial Post, Cannamedical Pharma GmbH imported medical cannabis products on Sept. 9. “The European market is clearly developing its ability to grow and ship world-class medicinal cannabis products, which is an important step in the development of the EU medicinal cannabis market, which we believe will be the world’s largest,” said David Henn, CEO of Cannamedical, to the Financial Post. “Cannamedical continues to demonstrate that our approach as the leading independent importer of finding the best products in all supply markets to serve to our patients can establish milestones within the industry. We are proud of the contribution we are making to provide a stable supply of medicinal cannabis to patients in Germany and thankful for our world-class supply partners.” The medical cannabis amounts to an estimated value of $3.3 million.
The shipment contained medical cannabis in oil form. Once the product is tested, it will be properly packaged and become available for patients as early as mid-October.
So far, Cannamedical Pharma GmbH is the only company to successfully distribute products using their own brand name in Germany. Earlier this year in May, the company announced that it had entered into a supply agreement with three suppliers. As of this writing, the company now holds nine supply agreements with companies across three different continents. One of the suppliers is Tilray, which has become well-known in the cannabis space. “We at Cannamedical Pharma are committed to helping doctors, medical specialists and pharmacists improve their patients’ quality of life,” said Cannamedical CEO David Henn in a press release. “Tilray’s product has passed our strict quality control standards, and we’re excited to have found a partner able to deliver medical cannabis products for use in Cannamedical’s own brands. We look forward to increasing access for patients in need across the country.”
In addition to these imports, German officials have also recently granted licenses for domestic cannabis cultivation. In a month’s time, the state of patient access in Germany could look very different.